DNA vaccine trains immune system to fight brain cancer
Disease control
Completed
This early-stage trial tests a DNA vaccine called ITI-1001 in people with newly diagnosed glioblastoma, an aggressive brain cancer. The vaccine is designed to teach the immune system to recognize and attack cancer cells that carry common cytomegalovirus (CMV) proteins. About 10 p…
Phase: PHASE1 • Sponsor: Immunomic Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC